Praxis Precision Medicines proposes stock offering, shares slip
- Praxis Precision Medicines (NASDAQ:PRAX) said Thursday it plans to conduct a public offering of its common stock.
- All shares in the offering will be offered by the company.
- The underwriters are expected to have a 30-day option to purchase up to an additional 15% of the shares of common stock.
- Piper Sandler and Truist Securities will act as the joint book-running managers for the proposed offering.
- Details on pricing and the number of shares to be offered were not disclosed.
- Press Release.
- Shares -11.6% at 80 cents after hours.